WHO Collaborating Centre for Campylobacter
Our WHO Collaborating Centre supports the World Health Organization with expertise on food safety and antimicrobial resistance
The work of the WHO-CC covers Campylobacter jejuni and C. coli as causes of diarrhoea in humans and the sequelae of the infection (e.g. Guillain Barre syndrome, reactive arthritis), and C. fetus, the species that can cause severe invasive infections in humans. The WHO-CC also supports WHO in the control of antimicrobial resistance, in particular from the One Health perspective.
The terms of reference for our WHO-CC designation are as follows:
- To support WHO's efforts to build the capacity of Member States to develop (integrated) surveillance, attribute human illness to specific sources and develop intervention strategies to prevent and control human campylobacteriosis, including attention for antimicrobial resistance in Campylobacter and antimicrobial resistance in a broader perspective.
- To organise scientific meetings, educational activities, individual and group training, on laboratory techniques, the development and implementation of prevention and intervention strategies, and on antimicrobial resistance (in collaboration with WHO CC for Antimicrobial Resistance in Foodborne Pathogens (DEN-52)).
- To develop new techniques and improved tools for Campylobacter isolation, identification and typing, and antimicrobial resistance which can be used to support surveillance, attribution and intervention studies.
- To compile and disseminate state-of-the-art information for WHO and member states on surveillance, laboratory techniques, susceptibility and strategies to prevent and control human campylobacteriosis and containment of antimicrobial resistance.
- To provide reference services for Member States for isolation, identification, typing and susceptibility testing of Campylobacter from a variety of matrices for veterinary, food and public health laboratories and to provide expertise to WHO and member states about the epidemiological relevance of the results.
- To act as mentor/coach in longstanding (collaborative) projects with specific countries to build capacity and support the development of regional and country specific strategies to prevent and control human campylobacteriosis and to investigate and contain antimicrobial resistance.
If you need any advice or assistance on Campylobacter diagnostics or research, contact us: Professor Jaap A. Wagenaar. Telephone: +31 30 253 4376.
Faculty of Veterinary Medicine
Division of Clinical Infectiology
Att. Prof. Jaap Wagenaar, PhD
P.O. box 80.165
3508 TD Utrecht
3584 CL Utrecht